Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.
FAS-independent cell death of HTLV-1-specific clonal cytotoxic T cells upon exposure to autologous HTLV-1-bearing leukemic cells (Meeting abstract).
Proc Annu Meet Am Soc Clin Oncol; 14:A20 1995. Unique Identifier : AIDSLINE ICDB/95613176 Anderson B; Maeda H; Maeda Y; Lam L; Yang Y; Mitsuya H; NCI, Bethesda, MD 20892
Abstract:
HTLV-l-specific clonal cytotoxic T cells (CTL) were generated from a patient with adult T-cell leukemia (ATL). The CTL killed autologous leukemic cells (ALC); however, the coculture resulted in decreased proliferation and death of the CTL. We explored the possible mechanisms of this CTL cell death. Coculture of CTL and irradiated ALC caused a significant degree of CTL DNA fragmentation as demonstrated by DNA filtration assay and extraction of 14C-labeled low molecular weight DNA. This DNA fragmentation was not inhibited by cyclosporin A, dexamethasone, actinomycin D, or cycloheximide suggesting a mechanism independent of the activation state of the CTL. The CTL express functional Fas antigen as demonstrated by fluorescence-activated cell analysis, and cell death, measured by 51Cr-release assay, was found to occur when CTL were incubated with an anti-Fas IgM monoclonal antibody. Preincubation of CTL with myristate acetate phorbol (PMA) virtually completely inhibited the ALC-induced cell death, although it only partially inhibited the anti-Fas IgM-induced CTL death. Also, preincubation of ALC with soluble Fas antigen failed to block the subsequent death of 51Cr-labeled CTL. Finally, when ALC were cocultured with the Fas+ L1210 cell line, no evidence of L1210 cell death was seen. These data suggest that the ALC-induced CTL death is not related to the proposed apoptotic mechanisms requiring cell activation and is not mediated by a Fas-dependent process. The inhibition of this apoptotic process by PMA suggests that an intracellular mechanism leading to the death of the CTL is operating. This phenomenon may suggest a mechanism for the progressive decline of the immune system in patients with ATL.
Keywords: Antibodies, Monoclonal/PHARMACOLOGY Antigens, Surface/IMMUNOLOGY/*PHYSIOLOGY *Apoptosis Cell Communication Cell Death Cells, Cultured Human HTLV-I IgM/PHARMACOLOGY Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated/*IMMUNOLOGY/ *PATHOLOGY T-Lymphocytes, Cytotoxic/*PATHOLOGY Tumor Cells, Cultured ABSTRACT 950930
M9591318
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.